Tissue-Resident Lymphocytes: Implications in Immunotherapy for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a hard-to-treat cancer. The recent introduction of immune checkpoint inhibitors (ICIs) provided viable options to treat HCC, but the response rate is currently not sufficient. Thus, a better understanding of ICI-responding cells within tumors is needed to improve ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ji Won, Yoon, Seung Kew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796120/
https://www.ncbi.nlm.nih.gov/pubmed/33379384
http://dx.doi.org/10.3390/ijms22010232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796120/
https://www.ncbi.nlm.nih.gov/pubmed/33379384
http://dx.doi.org/10.3390/ijms22010232

Ejemplares similares